Europe's 'Horizon 2020' science funding programme: how is it shaping up?

被引:18
|
作者
Galsworthy, Michael [1 ,2 ]
McKee, Martin [3 ]
机构
[1] UCL, Dept Appl Hlth Res, London WC1E 7HB, England
[2] Royal Coll Anaesthetists, Natl Inst Acad Anaesthesia Hlth Serv Res Ctr, London, England
[3] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London, England
基金
加拿大健康研究院;
关键词
Eastern Europe; Horizon; 2020; ORCID;
D O I
10.1177/1355819613476017
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Over the past 15 years, the European Union (EU) has spent around Euro80 billion on science research via Framework Programmes (FP5, FP6 and FP7). In 2014, a new programme, Horizon 2020, will likely invest another Euro70 billion over 6 years. Health research has been a major part: between 12% and 17% was spent on official FP5 and FP6 health research lines, although our work categorizing all EU science projects puts the health-related investment proportion nearer to 20%. Here, we compare our analyses and experiences with the European Commission's own impact assessments and plans that inform the Horizon 2020 programme. Much is moving in the right direction but some key gaps are overlooked. We discuss four areas: red tape, what to fund, harnessing informatics and neglect of Eastern Europe.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 50 条